These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 25421653)
1. Community resources and technologies developed through the NIH Roadmap Epigenomics Program. Satterlee JS; Beckel-Mitchener A; McAllister K; Procaccini DC; Rutter JL; Tyson FL; Chadwick LH Methods Mol Biol; 2015; 1238():27-49. PubMed ID: 25421653 [TBL] [Abstract][Full Text] [Related]
2. The NIH Common Fund/Roadmap Epigenomics Program: Successes of a comprehensive consortium. Satterlee JS; Chadwick LH; Tyson FL; McAllister K; Beaver J; Birnbaum L; Volkow ND; Wilder EL; Anderson JM; Roy AL Sci Adv; 2019 Jul; 5(7):eaaw6507. PubMed ID: 31501771 [TBL] [Abstract][Full Text] [Related]
3. The NIH Roadmap Epigenomics Program data resource. Chadwick LH Epigenomics; 2012 Jun; 4(3):317-24. PubMed ID: 22690667 [TBL] [Abstract][Full Text] [Related]
4. The impact of epigenomics on future drug design and new therapies. Hamm CA; Costa FF Drug Discov Today; 2011 Jul; 16(13-14):626-35. PubMed ID: 21570477 [TBL] [Abstract][Full Text] [Related]
6. The Einstein Center for Epigenomics: studying the role of epigenomic dysregulation in human disease. McLellan AS; Dubin RA; Jing Q; Maqbool SB; Olea R; Westby G; Broin PÓ; Fazzari MJ; Zheng D; Suzuki M; Greally JM Epigenomics; 2009 Oct; 1(1):33-8. PubMed ID: 22122636 [TBL] [Abstract][Full Text] [Related]
7. Make way for the 'next generation': application and prospects for genome-wide, epigenome-specific technologies in endocrine research. Emes RD; Farrell WE J Mol Endocrinol; 2012 Aug; 49(1):R19-27. PubMed ID: 22525352 [TBL] [Abstract][Full Text] [Related]
8. Single-molecule, genome-scale analyses of DNA modifications: exposing the epigenome with next-generation technologies. Zillner K; Németh A Epigenomics; 2012 Aug; 4(4):403-14. PubMed ID: 22920180 [TBL] [Abstract][Full Text] [Related]
9. Identifying co-opted transposable elements using comparative epigenomics. Venuto D; Bourque G Dev Growth Differ; 2018 Jan; 60(1):53-62. PubMed ID: 29363107 [TBL] [Abstract][Full Text] [Related]
10. From profiles to function in epigenomics. Stricker SH; Köferle A; Beck S Nat Rev Genet; 2017 Jan; 18(1):51-66. PubMed ID: 27867193 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic biomarkers in cancer epidemiology. Verma M Methods Mol Biol; 2012; 863():467-80. PubMed ID: 22359311 [TBL] [Abstract][Full Text] [Related]
12. The International Human Epigenome Consortium Data Portal. Bujold D; Morais DAL; Gauthier C; Côté C; Caron M; Kwan T; Chen KC; Laperle J; Markovits AN; Pastinen T; Caron B; Veilleux A; Jacques PÉ; Bourque G Cell Syst; 2016 Nov; 3(5):496-499.e2. PubMed ID: 27863956 [TBL] [Abstract][Full Text] [Related]
13. Next-generation technologies and data analytical approaches for epigenomics. Mensaert K; Denil S; Trooskens G; Van Criekinge W; Thas O; De Meyer T Environ Mol Mutagen; 2014 Apr; 55(3):155-70. PubMed ID: 24327356 [TBL] [Abstract][Full Text] [Related]
14. [Epigenome: the immersed part of the iceberg or the hidden face of pathologies]. Alliel PM; Rieger F; Goudou D Pathol Biol (Paris); 2010 Dec; 58(6):e91-3. PubMed ID: 19299093 [No Abstract] [Full Text] [Related]
15. Genetic sources of population epigenomic variation. Taudt A; Colomé-Tatché M; Johannes F Nat Rev Genet; 2016 Jun; 17(6):319-32. PubMed ID: 27156976 [TBL] [Abstract][Full Text] [Related]
16. Using epigenomic studies in monozygotic twins to improve our understanding of cancer. Roos L; Spector TD; Bell CG Epigenomics; 2014 Jun; 6(3):299-309. PubMed ID: 25111484 [TBL] [Abstract][Full Text] [Related]